Clinical Trials Browser

Phase 3 × Completed × apaziquone × Clear all

NCT00461591 2021-03-30

Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611)

Phase 3 Completed

802 enrolled 20 charts

Urinary Bladder Neoplasms

NCT00598806 2017-11-13

Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)

Phase 3 Completed

812 enrolled 20 charts

Urinary Bladder Neoplasms